corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism International News

October 2002

REFERENCES

Armstrong, D., Reyburn, H. & Jones, R.  (1996).  A study of general practitioners’ reasons for changing their prescribing behaviour.  British Medical Journal, 312, 949-952.

Association of Teachers of Ethics and Law in Australia and New Zealand Medical Schools (ATEAM).  (2001).  Position Statement: An ethics core curriculum for Australasian medical schools.  Medical Journal of Australia, 175, 205-210.

Australian Medical Association.  (1996).  Code of Ethics.  Position Statements [On-line].  Available: http://domino.ama.com.au/AMA/.

Avorn, J., Chren, M. & Hartley, R.  (1982).  Scientific vs commercial sources of influence on the prescribing behaviour of physicians.  American Journal of Medicine, 73, 4-8.

Backer, E., Lebsack, J., Van Tonder, R. & Crabtree, B.  (2000).  The value of pharmaceutical representative visits and medication samples in community-based medicine.  Journal of Family Practice, 49(9), 811-820.

Beary, J.  (1996).  Pharmaceutical marketing has real and proven value.  Journal of General Internal Medicine, 11, 575-583.

Berings, D., Blondeel, L. & Habraken, H.  (1994).  The effect of industry-independent drug information on the prescribing of benzodiazepines in general practice.  European Journal of Clinical Pharmacology, 46, 501-505.

Billig, M.  (1987).  Arguing and Thinking: A rhetorical approach to social psychology.  Cambridge: Cambridge University Press.

Billig, M.  (1991).  Ideologies and beliefs.  London: Sage.

Billig, M., Condor, S., Edwards, D., Gane, M., Middleton, D. & Radley, A.  (1988).  Ideological Dilemmas: A social psychology of everyday thinking.  London: Sage Publications.

Bower, A. & Burkett, G.  (1987).  Family physicians and generic drugs.  Journal of Family Practice, 24, 612-616.

Breen, K.  (2001).  Professional development and ethics for today’s and tomorrow’s doctors: There is no lack of ethical and professional challenges for doctors.  Medical Journal of Australia, 175, 183-184.

Brotzman, G. & Mark, D.  (1993).  The effect on residents attitudes of regulatory policies regarding pharmaceutical representatives activities.  Journal of General Internal Medicine, 8, 130-134.

Caudill, T., Johnson, M., Rich, E. & McKinney, P.  (1996).  Physicians, pharmaceutical sales representatives and the cost of prescribing.  Archives of Family Medicine, 5, 201-206.

Chren, M. & Landefeld, C.  (1994).  Physicians’ behaviour and their interactions with drug companies.  Journal of The American Medical Association, 271, 684-689.

Chren, M., Landefeld, C. & Murray, T.  (1989).  Doctors, drug companies, and gifts.  Journal of The American Medical Association, 262, 3448-3451.

Gill, P., Freemantle, N., Bero, L., Haaijer-Ruskamp, F., Markela, M. & Barjesteh, K.  (1996).  GPs’ prescribing behaviour may be affected by drug promotion [Letter to the editor].  British Medical Journal, 313, 367.

Goddard, M., Henry, D. & Birkett, D.  (2001).  Costs and benefits: Securing the future of the pharmaceutical benefits scheme.  Unpublished manuscript.

Goffman, I.  (1981).  Forms of Talk.  Oxford: Basil Blackwell.

Greenhalgh, T.  (1997).  Papers that report drug trials (How to read a paper, part 6).  British Medical Journal, 315, 480-484.

Griffith, D.  (1999).  Reasons for not seeing drug representatives.  British Medical Journal, 319, 69-70.

Haayer, F.  (1982).  Rational prescribing and sources of information.  Social Science of Medicine, 16, 2017-2023.

Jones, M., Greenfield, S. & Bradley, C.  (2001).  Prescribing new drugs: Qualitative study of influences on consultants and general practitioners.  British Medical Journal, 323, 1-7.

Lexchin, J.  (1989).  Doctors and detailers: Therapeutic education or pharmaceutical promotion?  International Journal of Health Sciences, 19, 663-679.

Lexchin, J.  (1993).  Interactions between physicians and the pharmaceutical industry: What does the literature say?  Canadian Medical Association Journal, 149, 1401-1407.

Light, E.  (2001, September 3).  Docs charge reps for time [World round-up].  Australian Medicine, p. 2.

McKinney, W., Schiedermayer, D., Lurie, N., Simpson, D., Goodman, J. & Rich, E.  (1990).  Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives.  Journal of The American Medical Association, 264, 1693-1697.

Mansfield, P.  (2001, Summer).  Pushing expensive new drugs.  Consuming Interest, p. 27-29.

Mansfield, P. & Lexchin, J.  (2000).  Scepticism and beliefs about new drugs.  Unpublished manuscript.

Morelli, D. & Koenigsberg, M.  (1992).  Sample medication dispensing in a residency practice.  Journal of Family Practice, 34, 42-47.

Moscovici, S.  (1984).  The phenomenon of social representations, in R. M. Farr and S. Moscovici (Eds.), Social Representations.  Cambridge: Cambridge University Press.

Murphy, K.  (1999, May 28).  Guidelines on when to reject gift offers.  Australian Doctor, p. 8.

Orlowski, J. & Wateska, L.  (1992).  The effects of pharmaceutical firm enticements on physician prescribing patterns: There’s no such thing as a free lunch.  Chest, 102(1), 270-273.

Peay, M. & Peay, R.  (1988).  The role of commercial sources in the adoption of a new drug.  Social Science and Medicine, 26, 1183-1189.

Pomerantz, A.  (1986).  Extreme case formulations: A new way of legitimating claims.  Human Studies, 9, 219-230.

Potter, J.  (1996).  Representing Reality: Discourse, rhetoric and social construction.  London: SAGE Publications Ltd.

Potter, J. & Wetherell, M.  (1987).  Discourse and social psychology: Beyond attitudes and behaviour.  London: SAGE Publications Ltd.

Roughead, E.  (1995).  The pharmaceutical representative and medical practitioner encounter: Implications for quality use of medicines.  Unpublished master’s thesis, Latrobe University, Melbourne, Victoria, Australia.

Shaughnessy, A. & Slawson, D.  (1996).  Pharmaceutical representatives.  British Medical Journal, 312, 1494-1995.

Siegal, D. & Lopez, J.  (1997).  Trends in antihypertensive drug use in the United States: Do the JNC V recommendations affect prescribing?  Journal of The American Medical Association, 278, 1745-1748.

Steinman, M., Shlipak, M. & McPhee, S.  (2001).  Of principles and pens: Attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.  The American Journal of Medicine, 110, 551-557.

Susman, E.  (2001, July 17).  U.S. doctors touchy on topic of pharmaceutical gifts.  The Medical Post, p. 9.

Thomson, A., Craig, B. & Barham, P.  (1994).  Attitudes of general practitioners in New Zealand to pharmaceutical representatives.  British Journal of General Practice, 44, 220-226.

Wazana, A.  (2000).  Physicians and the pharmaceutical industry: Is a gift ever just a gift?  The Journal of the American Medical Association, 283(3), 373-383.

Westfall, J., McCabe, J. & Nicholas, R.  (1997).  Personal use of drug samples be physicians and office staff.  The Journal of the American Medical Association, 278, 141-143.

Westfall, J.  (1998, June).  Drug samples: Benefit or bait? [Letter in reply to letter to the editor].  The Journal of the American Medical Association, 279, 1698-1700.

Westfall, J.  (2000).  Physicians, pharmaceutical representatives, and patients: Who really benefits?  Journal of Family Practice, 49(9), 817-820.

Wetherell, M. & Potter, J.  (1992).  Mapping the language of racism: Discourse and the legitimisation of exploitation.  London: Harvester Wheatsheaf.

Wolf, B.  (1998, June).  Drug samples: Benefit or bait? [Letter to the editor].  The Journal of the American Medical Association, 279(21), 1698-1700.

Woolgar, S. & Pawluch, D.  (1985).  Ontological gerry-mandering: The anatomy of social problems explanations.  Social Problems, 32, 214-227.

Ziegler, M., Lew, P. & Singer, B.  (1995).  The accuracy of drug information from pharmaceutical sales representatives.  The Journal of the American Medical Association, 273, 1296-1298.

 

 

HS Int News index

 

Comments

Our members can see and make comments on this page.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others. The contents of this page are the author's views and do not necessarily reflect the position of Healthy Skepticism or other members of Healthy Skepticism.

  • E-mail
  • LinkedIn
  • Del.icio.us
  • Digg
  • Facebook
  • FriendFeed
  • Google Bookmarks
  • MySpace
  • Reddit
  • Slashdot
  • StumbleUpon
  • Tumblr
  • Twitter
  • Yahoo! Bookmarks








There is no sin in being wrong. The sin is in our unwillingness to examine our own beliefs, and in believing that our authorities cannot be wrong. Far from creating cynics, such a story is likely to foster a healthy and creative skepticism, which is something quite different from cynicism.”
- Neil Postman in The End of Education